Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth

BioAsia 2025 has set the stage for Hyderabad to solidify its position as a global life sciences hub. With 11 pharmaceutical companies pledging investments worth Rs 5,445 crore and creating 9,800 jobs, the sector is witnessing strong momentum. The total investment in Green Pharma City has now surged to Rs 11,100 crore, supporting over 22,300 jobs.

The Telangana government is attracting key global players, with MSD, a US-based pharma giant, expanding into the state’s thriving ecosystem. Los Angeles-based Agilisium has launched a Life Sciences Innovation & Talent Development Lab at RMZ Spire, Hyderabad, enhancing digital health capabilities.

The industry is also seeing major expansions in Hyderabad. ALS, a global leader in testing and certification, is establishing a cutting-edge cGMP biopharma testing lab in Genome Valley. Meishi Pharma, a subsidiary of Lotus, is setting up its second R&D centre in the city.

Telangana is driving international collaborations, signing a Letter of Intent with the University of Queensland to advance research, digital healthcare, and AI-driven innovations. The state will also become India’s first hub under the World Economic Forum’s “Indian Digital Health Activator.”

Additionally, 11 leading contract research and development organizations have come together to enhance industry collaboration, talent development, regulatory efficiency, and supply chain strength, further positioning Hyderabad as a global leader in life sciences.